• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Allecra Therapeutics - Articles and news items

AAI202

Allecra Therapeutics closes €22 Million Series B financing round

Industry news / 15 June 2016 / Victoria White, Digital Content Producer

The proceeds will fund Phase II development of AAI202 – a novel antibiotic combination designed to treat drug-resistant Gram-negative bacterial infections…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +